Azithromycin

Alternative Names: Z-pack

Azithromycin is a macrolide antibiotic commonly used for the treatment of mild to moderate community-acquired pneumonia (CAP). It is particularly effective against atypical pathogens such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila, as well as some Gram-positive and Gram-negative bacteria, including Streptococcus pneumoniae and Haemophilus influenzae.

Often combined with a beta-lactam antibiotic (e.g., amoxicillin, amoxicillin-clavulanate, ceftriaxone) in moderate to severe CAP or for patients with comorbidities.

Treatment Type: Prescription Medication

Treatment Class: Macrolide

Treatment Modality: Intravenous (IV), Oral

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Based on the limited information provided, with only one review and a rating of 5 out of 5, Azithromycin appears to be an effective treatment for outpatient community-acquired pneumonia. However, more reviews and detailed information would be needed to make a more comprehensive assessment of the treatment's effectiveness.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
5.0
1 = Very Expensive 5 = Very Affordable

5.0

Very Affordable
Relief Speed
3.0
1 = No Relief 5 = Immediate Relief

3.0

Moderate Relief
Side Effects
4.0
1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect
Treatment Line
5.0
1 = Third-line or more 5 = First-line

5.0

First-line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews
5
100%
4
0%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the limited information provided, with only one review and a rating of 5 out of 5, Azithromycin appears to be an effective treatment for outpatient community-acquired pneumonia. However, more reviews and detailed information would be needed to make a more comprehensive assessment of the treatment's effectiveness.

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
2 months ago
A common go-to for community-acquired pneumonia, especially when atypical coverage is needed. It’s a convenient 5-day course and generally well tolerated. Easy to use, though resistance patterns and local guidelines should be considered.
#VeryAffordable #ModerateRelief #MildEffect #First-line #Rescue/EmergencyUse